Literature DB >> 10364280

p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

J N Harada1, A J Berk.   

Abstract

The adenovirus type 5 mutant dl1520 was engineered previously to be completely defective for E1B-55K functions. Recently, this mutant (also known as ONYX-015) has been suggested to replicate preferentially in p53(-) and some p53(+) tumor cell lines but to be attenuated in primary cultured cells (C. Heise, A. Sampson-Johannes, A. Williams, F. McCormick, D. D. F. Hoff, and D. H. Kirn, Nat. Med. 3:639-645, 1997). It has been suggested that dl1520 might be used as a "magic bullet" that could selectively lyse tumor cells without harm to normal tissues. However, we report here that dl1520 replication is independent of p53 genotype and occurs efficiently in some primary cultured human cells, indicating that the mutant virus does not possess a tumor selectivity. Although it was not the sole host range determinant, p53 function did reduce dl1520 replication when analyzed in a cell line expressing temperature-sensitive p53 (H1299-tsp53) (K. L. Fries, W. E. Miller, and N. Raab-Traub, J. Virol. 70:8653-8659, 1996). As found earlier for other E1B-55K mutants in HeLa cells (Y. Ho, R. Galos, and J. Williams, Virology 122:109-124, 1982), dl1520 replication was temperature dependent in H1299 cells. When p53 function was restored at low temperature in H1299-tsp53 cells, it imposed a modest defect in viral DNA replication and accumulation of late viral cytoplasmic mRNA. However, in both H1299 and H1299-tsp53 cells, the defect in late viral protein synthesis appeared to be much greater than could be accounted for by the modest defects in late viral mRNA levels. We therefore propose that in addition to countering p53 function and modulating viral and cellular mRNA nuclear transport, E1B-55K also stimulates late viral mRNA translation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364280      PMCID: PMC112589     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  85 in total

1.  Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence.

Authors:  M Dobbelstein; J Roth; W T Kimberly; A J Levine; T Shenk
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

2.  Killing tumor cells with viruses--a question of specificity.

Authors:  D P Lane
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

3.  p53-dependent cell death/apoptosis is required for a productive adenovirus infection.

Authors:  A R Hall; B R Dix; S J O'Carroll; A W Braithwaite
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

4.  Cancer. Has the smart bomb been defused?

Authors:  S P Linke
Journal:  Nature       Date:  1998-09-03       Impact factor: 49.962

5.  p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection.

Authors:  F D Goodrum; D A Ornelles
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

6.  Adenovirus E1B 55K represses p53 activation in vitro.

Authors:  M E Martin; A J Berk
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.

Authors:  W T Steegenga; N Riteco; A G Jochemsen; F J Fallaux; J L Bos
Journal:  Oncogene       Date:  1998-01-22       Impact factor: 9.867

8.  p53/E1b58kDa complex regulates adenovirus replication.

Authors:  P J Ridgway; A R Hall; C J Myers; A W Braithwaite
Journal:  Virology       Date:  1997-10-27       Impact factor: 3.616

9.  Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins.

Authors:  J Roth; C König; S Wienzek; S Weigel; S Ristea; M Dobbelstein
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells.

Authors:  T Rothmann; A Hengstermann; N J Whitaker; M Scheffner; H zur Hausen
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  57 in total

1.  Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.

Authors:  Ramon A Gonzalez; S J Flint
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 2.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Replication of an E1B 55-kilodalton protein-deficient adenovirus (ONYX-015) is restored by gain-of-function rather than loss-of-function p53 mutants.

Authors:  Byron Hann; Allan Balmain
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells.

Authors:  C-Q Su; J Sham; H-B Xue; X-H Wang; D Chua; Z-F Cui; L-H Peng; L-F Li; L-H Jiang; M-C Wu; Q-J Qian
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-09       Impact factor: 4.553

5.  E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.

Authors:  Urs Hobom; Matthias Dobbelstein
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

6.  Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells.

Authors:  Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.

Authors:  Jennifer L Woo; Arnold J Berk
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts.

Authors:  Ramon Gonzalez; Wenying Huang; Renee Finnen; Courtney Bragg; S J Flint
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

9.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 10.  Adenoviral vector-mediated gene therapy for gliomas: coming of age.

Authors:  Maria G Castro; Marianela Candolfi; Thomas J Wilson; Alexandra Calinescu; Christopher Paran; Neha Kamran; Carl Koschmann; Mariela A Moreno-Ayala; Hikmat Assi; Pedro R Lowenstein
Journal:  Expert Opin Biol Ther       Date:  2014-04-29       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.